254 related articles for article (PubMed ID: 31454708)
21. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
22. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
[TBL] [Abstract][Full Text] [Related]
23. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
[TBL] [Abstract][Full Text] [Related]
24. Overcoming Multidrug-Resistance in Bacteria with a Two-Step Process to Repurpose and Recombine Established Drugs.
Sun J; Wang B; Warden AR; Cui D; Ding X
Anal Chem; 2019 Nov; 91(21):13562-13569. PubMed ID: 31565925
[TBL] [Abstract][Full Text] [Related]
25. Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
Vipin C; Saptami K; Fida F; Mujeeburahiman M; Rao SS; Athmika ; Arun AB; Rekha PD
PLoS One; 2020; 15(11):e0241304. PubMed ID: 33156838
[TBL] [Abstract][Full Text] [Related]
26. Repurposing bioactive compounds for treating multidrug-resistant pathogens.
Hummell NA; Kirienko NV
J Med Microbiol; 2020 Jun; 69(6):881-894. PubMed ID: 32163353
[No Abstract] [Full Text] [Related]
27. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
[TBL] [Abstract][Full Text] [Related]
28. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
[TBL] [Abstract][Full Text] [Related]
29. Repurposed drug candidates for antituberculosis therapy.
An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
[TBL] [Abstract][Full Text] [Related]
30. Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
Kirienko NV; Rahme L; Cho YH
Front Cell Infect Microbiol; 2019; 9():343. PubMed ID: 31681623
[No Abstract] [Full Text] [Related]
31. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
[TBL] [Abstract][Full Text] [Related]
32. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
33. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
[TBL] [Abstract][Full Text] [Related]
34. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
[TBL] [Abstract][Full Text] [Related]
35. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
Zarakolu P; Ayaz ÇM; Metan G
Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736
[TBL] [Abstract][Full Text] [Related]
36. Drug repurposing for the treatment of staphylococcal infections.
Thangamani S; Mohammad H; Younis W; Seleem MN
Curr Pharm Des; 2015; 21(16):2089-100. PubMed ID: 25760334
[TBL] [Abstract][Full Text] [Related]
37. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
[TBL] [Abstract][Full Text] [Related]
38. CombiANT: Antibiotic interaction testing made easy.
Fatsis-Kavalopoulos N; Roemhild R; Tang PC; Kreuger J; Andersson DI
PLoS Biol; 2020 Sep; 18(9):e3000856. PubMed ID: 32941420
[TBL] [Abstract][Full Text] [Related]
39. Repurposing approved drugs on the pathway to novel therapies.
Schein CH
Med Res Rev; 2020 Mar; 40(2):586-605. PubMed ID: 31432544
[TBL] [Abstract][Full Text] [Related]
40. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
Phee LM; Betts JW; Bharathan B; Wareham DW
Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
